VN
EN
Close Menu
Home page
About Us
About Imexpharm
Our Culture
Our Journey
People
Potential
News
Imexpharm News
Events
Specialized
Investor Events
Community Activities
Products
Product Groups
Products A-Z
Investors
Investor events
AGM
BOD Resolutions
Information Disclosure
IR News
Financial Statements
Annual Reports
Sustainability Reports
Search All
Corporate Governance
Search All
Our Charter
Management Regulations
Corporate Governance Reports
Prospectus
Code of Conduct
Community
Careers
Media
Contact
Home
Investors
Investor documents
Information Disclosure
IMP - Report on the results of the 2023 dividend stock issuance
07/18/2024
IMP - Imexpharm's Charter - October 2024
10/01/2024
IMP - Official letter of the SSC approving the results of share issuance to increase charter capital from owner's equity
10/01/2024
IMP - Notice of the record date to collect shareholders' written opinions
09/30/2024
IMP - BOD Resolution No.16 regarding the liquidation of certain assets that are no longer needed to be held or used
09/28/2024
IMP - BOD Resolution No. 15 on collecting shareholders' opinions in writing
09/28/2024